| |
| |
|
| Insider
Information: |
Moll Frederic H |
| Relationship: |
Director |
| City: |
Sunnyvale |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
5,856,461 |
|
|
Indirect Shares
|
183,960 |
|
|
| Direct
Value |
$340,482,308 |
|
|
|
Indirect Value
|
$11,236,685 |
|
|
| Total
Shares |
6,040,421 |
|
|
| Total
Value |
$351,718,993 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 27.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Intuitive Surgical Inc |
ISRG |
Director |
2003-09-10 |
657,799 |
2003-08-13 |
0 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2012-03-01 |
2,640,077 |
2012-03-01 |
150,000 |
Premium* |
|
|
Mako Surgical Corp. |
MAKO |
Director |
2013-12-17 |
0 |
2008-10-31 |
0 |
Premium* |
|
|
Intersect Ent, Inc. |
XENT |
|
2021-01-19 |
260,961 |
2014-07-29 |
0 |
Premium* |
|
|
Biolase Inc |
BIOL |
Director |
2017-06-30 |
251,317 |
2015-08-27 |
0 |
Premium* |
|
|
Venus Concept Inc |
VERO |
Director |
2019-11-07 |
950,553 |
2017-10-16 |
0 |
Premium* |
|
|
Shockwave Medical, Inc. |
SWAV |
Director |
2024-02-21 |
287,521 |
2023-06-13 |
33,960 |
Premium* |
|
|
Procept Biorobotics Corp |
PRCT |
Director |
2023-12-06 |
808,233 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MAKO |
Mako Surgical Corp. |
Director |
– • – |
2013-12-17 |
4 |
D |
$30.00 |
$7,025,040 |
D/D |
(234,168) |
0 |
0 |
- |
|
| HNSN |
Hansen Medical Inc |
Chief Executive Officer |
• • – |
2007-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,647 |
1,166 |
0 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2015-08-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,217 |
9,217 |
0 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2017-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,000 |
59,217 |
0 |
- |
|
| MAKO |
Mako Surgical Corp. |
Director |
– • – |
2008-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
69,795 |
69,795 |
0 |
- |
|
| MAKO |
Mako Surgical Corp. |
Director |
– • – |
2008-02-20 |
4 |
B |
$10.00 |
$23,500 |
D/D |
2,350 |
72,145 |
2.39 |
- |
|
| MAKO |
Mako Surgical Corp. |
Director |
– • – |
2008-10-31 |
4 |
B |
$6.20 |
$250,003 |
D/D |
40,323 |
112,468 |
2.39 |
- |
|
| MAKO |
Mako Surgical Corp. |
Director |
– • – |
2009-11-20 |
4 |
B |
$9.01 |
$180,124 |
D/D |
20,000 |
132,468 |
2.39 |
- |
|
| MAKO |
Mako Surgical Corp. |
Director |
– • – |
2009-11-30 |
4 |
B |
$8.58 |
$85,793 |
D/D |
10,000 |
142,468 |
2.39 |
- |
|
| HNSN |
Hansen Medical Inc |
Chief Executive OfficerOfficer |
• • – |
2006-11-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
150,000 |
|
- |
|
| PRCT |
Procept Biorobotics Corp |
Director |
– • – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
152,631 |
|
- |
|
| VERO |
Venus Concept Inc |
Director |
– • – |
2019-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
145,394 |
207,381 |
0 |
- |
|
| MAKO |
Mako Surgical Corp. |
Director |
– • – |
2010-05-10 |
4 |
B |
$12.67 |
$950,385 |
D/D |
75,000 |
217,468 |
2.39 |
- |
|
| MAKO |
Mako Surgical Corp. |
Director |
– • – |
2011-06-08 |
4 |
B |
$30.49 |
$91,470 |
D/D |
3,000 |
220,468 |
2.39 |
- |
|
| MAKO |
Mako Surgical Corp. |
Director |
– • – |
2011-11-21 |
4 |
B |
$27.01 |
$99,946 |
D/D |
3,700 |
224,168 |
2.39 |
- |
|
| MAKO |
Mako Surgical Corp. |
Director |
– • – |
2011-12-09 |
4 |
B |
$24.95 |
$124,750 |
D/D |
5,000 |
229,168 |
2.39 |
- |
|
| SWAV |
Shockwave Medical, Inc. |
Director |
– • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
736 |
231,594 |
0 |
- |
|
| MAKO |
Mako Surgical Corp. |
Director |
– • – |
2012-05-11 |
4 |
B |
$24.15 |
$120,765 |
D/D |
5,000 |
234,168 |
2.39 |
- |
|
| XENT |
Intersect Ent, Inc. |
|
– • – |
2017-11-20 |
4 |
S |
$28.76 |
$71,895 |
D/D |
(2,500) |
239,624 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
|
– • – |
2018-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,514 |
241,138 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
|
– • – |
2017-11-17 |
4 |
S |
$28.74 |
$143,708 |
D/D |
(5,000) |
242,124 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
|
– • – |
2019-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,312 |
243,450 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
|
– • – |
2017-11-16 |
4 |
S |
$28.77 |
$192,764 |
D/D |
(6,700) |
247,124 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
|
– • – |
2020-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
5,011 |
248,461 |
0 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2017-06-30 |
4 |
OE |
$1.24 |
$238,204 |
D/D |
192,100 |
251,317 |
0 |
- |
|
65 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
